Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
about
Novel spectrophotometric method for determination of cinacalcet hydrochloride in its tablets via derivatization with 1,2-naphthoquinone-4-sulphonateRestoration of bone mineralization by cinacalcet is associated with a significant reduction in calcitriol-induced vascular calcification in uremic ratsTreatment options of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease stages 3 and 4: an historic review.Discovery of GPCR ligands for probing signal transduction pathways.Activation of the calcium-sensing receptor before renal ischemia/reperfusion exacerbates kidney injury.Asymmetric synthesis of nonracemic primary amines via spiroborate-catalyzed reduction of pure (E)- and (Z)-O-benzyloximes: applications toward the synthesis of calcimimetic agents.Simultaneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HClBehind the curtain: cellular mechanisms for allosteric modulation of calcium-sensing receptors.The calcimimetic R-568 induces apoptotic cell death in prostate cancer cells.Nonclinical Pharmacokinetics, Disposition, and Drug-Drug Interaction Potential of a Novel d-Amino Acid Peptide Agonist of the Calcium-Sensing Receptor AMG 416 (Etelcalcetide).Local calcitriol injections as a suppressive treatment of secondary hyperparathyroidism in chronic dialysis patients.Determinants of coronary artery calcification in maintenance hemodialysis patients.Efficacy and safety of Cinacalcet on secondary hyperparathyroidism in Chinese chronic kidney disease patients receiving hemodialysis.Therapeutic experience of severe and recurrent secondary hyperparathyroidism in a patient on hemodialysis for 18 years: A case report.
P2860
Q28397353-BD04F4F4-AD7C-45DD-B7F1-8B1D02DAE317Q28569272-FA34E5CC-0E1D-4974-BB82-A4C0A066BD4DQ33610289-A1C0227B-8D37-4B9F-A6EA-F74BA711C046Q34582707-95B2A2D6-2ABB-44E1-BF8B-2081B0A86F29Q35137812-B6913454-992F-424A-896B-C8B627BDA142Q37000185-A2AD38DF-C7D2-402C-A1D5-83F0DEB28D0DQ37330326-97F04A54-B1E4-4D2B-A127-BFA850E8AA7AQ37862353-99ED59FC-445B-4F26-9D5C-6E2F7B158539Q39825390-8D8FCCA3-9368-46A7-97F6-6B033A9C88A1Q43743367-35394E8C-01BE-4923-A767-F2A727198F08Q46860322-FD4788E3-1411-46E1-B708-F03BC549B8B8Q53019639-76D0A9FB-4A25-4C69-B3EC-26360FB2AF49Q53157310-76B96554-523A-4ACF-8954-57344DB3C751Q54936202-AE546DF1-A3CC-4B92-A206-05B3075DA7E8
P2860
Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Cinacalcet HCl: a novel treatm ...... sed by chronic kidney disease.
@ast
Cinacalcet HCl: a novel treatm ...... sed by chronic kidney disease.
@en
Cinacalcet HCl: a novel treatm ...... sed by chronic kidney disease.
@nl
type
label
Cinacalcet HCl: a novel treatm ...... sed by chronic kidney disease.
@ast
Cinacalcet HCl: a novel treatm ...... sed by chronic kidney disease.
@en
Cinacalcet HCl: a novel treatm ...... sed by chronic kidney disease.
@nl
prefLabel
Cinacalcet HCl: a novel treatm ...... sed by chronic kidney disease.
@ast
Cinacalcet HCl: a novel treatm ...... sed by chronic kidney disease.
@en
Cinacalcet HCl: a novel treatm ...... sed by chronic kidney disease.
@nl
P1476
Cinacalcet HCl: a novel treatm ...... sed by chronic kidney disease.
@en
P2093
Pablo Ureña Torres
P304
P356
10.1053/J.JRN.2006.04.010
P577
2006-07-01T00:00:00Z